Literature DB >> 18274462

Maxillofacial prosthodontics for the pediatric patient: "an eye-opening experience".

Shantanu Lal1, Aaron B Schwartz, Toral Gandhi, Melvin L Moss.   

Abstract

The following case report describes the expanding role of pediatric dentists in treating children with craniofacial pathology. Retinoblastoma is the most common intraocular malignancy in childhood and is approximately the tenth most common pediatric cancer in the United States. Treatment consists of enucleation, or removal of the entire globe followed by placement of orbital implants. Un-restored anopthalmic sockets exhibit growth retardation and can lead to facial disfigurement. Maxillofacial prosthetic (MFP) rehabilitation can be especially challenging in younger, pre-cooperative or behaviorally compromised children and requires the skills and participation of a pediatric dental specialist as part of the MFP team. The following case report involving a 3 yr-old girl with retinoblastoma describes such challenges. The objective of the maxillofacial prosthetic team was to provide custom-built, acrylic, bilateral ocular prostheses in as comfortable and atraumatic manner as possible. The case was a success and underscores the value of a multidisciplinary dental approach for the treatment of children with very special needs.

Entities:  

Mesh:

Year:  2007        PMID: 18274462     DOI: 10.17796/jcpd.32.1.wv77j52052147778

Source DB:  PubMed          Journal:  J Clin Pediatr Dent        ISSN: 1053-4628            Impact factor:   1.065


  2 in total

Review 1.  Ocular prosthesis incorporating IPS e-max press scleral veneer and a literature review on non-integrated ocular prosthesis.

Authors:  Godwin Clovis Da Costa; Meena Ajay Aras; Paul Chalakkal; Michelle Clovis Da Costa
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

2.  Fabrication of a custom ocular prosthesis.

Authors:  Tania Sethi; Mohit Kheur; Colin Haylock; Husain Harianawala
Journal:  Middle East Afr J Ophthalmol       Date:  2014 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.